Head of Global Manufacturing Science & Technology
- Employer
- Legend Biotech
- Location
- Bridgewater, New Jersey
- Posted date
- Sep 28, 2026
View more categories
- Discipline
- Manufacturing & Production, Manufacturing/Mechanical
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Pharm Country
By clicking apply, your email address will be shared with the employer.
Job Details
Legend Biotech is a global biotechnology company dedicated to treating and, one day, curing life-threatening diseases. Headquartered in Bridgewater, New Jersey, we are advancing the next generation of cell therapy through a portfolio of innovative technologies, including autologous, allogeneic, and in vivo cell therapy approaches. Our research spans chimeric antigen receptor T-cell (CAR-T), T-cell receptor (TCR-T), natural killer (NK) cell-based therapies, and other emerging platforms designed to transform the treatment of serious diseases. From our global network of research and development sites, we are committed to discovering and developing safe, effective, and cutting-edge therapies for patients worldwide.
Legend Biotech entered into a global collaboration agreement with Johnson & Johnson to jointly develop and commercialize CARVYKTI® (ciltacabtagene autoleucel; cilta-cel). Through this strategic partnership, we combine complementary expertise and capabilities to advance innovative immunotherapies for patients living with multiple myeloma.
Legend Biotech is seeking a Head of Global Manufacturing Science & Technology as part of the Manufacturing Science & Technology team based in Bridgewater, NJ.
Role Overview
The Head of Global Manufacturing Science & Technology (MSAT) is the enterprise technical leader responsible for ensuring the robustness, scalability, capability, and continuous improvement of manufacturing processes across the product lifecycle. The role establishes the global MSAT strategy and provides technical leadership from late-stage development and technology transfer through commercial manufacturing and lifecycle management. The Head of Global Manufacturing Science & Technology ensures that manufacturing processes are scientifically understood, technically capable, operationally robust, scalable, and continuously improved to support reliable supply, product quality, patient needs, and business growth.
As the enterprise technical authority for manufacturing processes, the Head of Global Manufacturing Science & Technology drives process robustness, technology transfer, process validation, continued process verification, technical investigations, manufacturing optimization, and advanced manufacturing capabilities across the global network. The incumbent will be a member of the GMS Leadership Team.
Key Responsibilities
Global MSAT Strategy & Technical Leadership
Define and execute the global MSAT strategy and operating model aligned with business, portfolio, and manufacturing priorities.
Establish global technical standards, capabilities, and governance for manufacturing processes across internal and external sites.
Serve as the senior technical authority for process capability, robustness, scalability, and manufacturing performance.
Process Technology & Manufacturing Performance
Own the technical strategy for process characterization, validation, process capability, continued process verification, and process monitoring.
Drive consistency and systematic improvement of manufacturing processes to increase yield, reliability, capacity, throughput, consistency, and cost efficiency.
Provide technical leadership for manufacturing investigations, process deviations, and recurring performance issues.
Establish science- and data-based approaches to identify process risks and proactively improve manufacturing performance.
Technology Transfer & Commercialization
Provide MSAT leadership for technology transfer and manufacturing readiness from development into commercial operations.
Ensure effective transfer of process knowledge, control strategies, technical standards, and manufacturing capabilities into internal and external manufacturing networks.
Partner with CMC and R&D to ensure development programs are designed for commercial scalability, manufacturability, and process robustness.
Provide technical input to major manufacturing network, capacity, and commercialization decisions.
Lifecycle Management & Continuous Improvement
Own the MSAT strategy for the technical lifecycle of commercial products, including process improvements, scale-up/scale-out, site transfers, capacity expansion, and manufacturing optimization.
Identify and prioritize opportunities to improve quality, yield, throughput, cost, cycle time, and supply resilience.
Lead implementation of advanced process technologies, automation, modeling, analytics, and digital manufacturing capabilities.
Ensure manufacturing knowledge and process data are systematically leveraged to drive continuous improvement.
Manufacturing & Global Network
Provide technical leadership, support and governance for MSAT activities at internal sites, CMOs/CDMOs and other external manufacturing partners.
Ensure consistent technical standards, process understanding, technology transfer, and lifecycle management across the global manufacturing network.
Partner with Manufacturing leadership to resolve technical, process, and performance issues.
Innovation, Digital & Advanced Manufacturing
Establish the strategic roadmap for advanced manufacturing technologies, automation, digital manufacturing, process analytics, and data science.
Accelerate adoption of emerging technologies that improve manufacturing control, predictability, flexibility, and efficiency.
Promote the use of data-driven and predictive approaches to enhance process understanding and manufacturing performance.
Executive Leadership & Organization
Build and lead a high-performing global MSAT organization with the technical depth and capabilities required to support a growing pipeline and commercial portfolio.
Develop organizational capabilities, talent, succession, and technical leadership across the global manufacturing network.
Serve as a senior member of the Global Manufacturing & Supply Leadership Team, contributing to manufacturing strategy, investment decisions, portfolio priorities, and supply resilience.
Act as a trusted technical advisor to senior leadership on major manufacturing, technology, process, and investment decisions.
Represent the company with strategic partners, regulators, industry organizations, and external technical forums.
Requirements
Advanced degree, preferably PhD in Chemical Engineering, Biological Sciences, Pharmaceutical Sciences, or related discipline.
20+ years of progressive experience in MSAT, process development, manufacturing science, technical operations, or related biopharmaceutical functions, including significant global leadership experience.
Proven global experience leading MSAT for commercial biopharmaceutical products, preferably including cell therapy, gene therapy, or other advanced modalities.
Strong expertise in process characterization, validation, technology transfer, CPV, process optimization, manufacturing technology, and lifecycle management.
Proven ability to lead complex technical decisions across R&D, CMC, Manufacturing, Quality, Regulatory, Engineering, and Supply Chain.
Enterprise technical leadership with strong business judgment.
Strong strategic thinking combined with technical depth.
Executive presence and ability to influence across functions and organizational boundaries.
Data-driven, scientifically rigorous, and highly pragmatic.
Strong innovation and continuous improvement mindset.
Develops people, builds capabilities, and creates a culture of technical excellence, accountability, and innovation.
#Li-BZ1
#Li-Hybrid
The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.
Other Types of Pay: Performance-based bonus and/or equity is available to employees in eligible roles.
Benefits and Paid Time Off: Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short- and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance. We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work.
Pay Range (Base Pay):
$271,800 - $360,000USD
Please note: These benefits are offered exclusively to permanent full-time employees. Contractors are not eligible for benefits through Legend Biotech.
Work Authorization & Employment Eligibility
Applicants must be authorized to work in the United States. As part of our commitment to maintaining a lawful workforce and ensuring compliance with federal employment regulations, we participate in the E-Verify program. If you are selected for employment, you will be required to complete the Form I-9 process, and your employment eligibility will be verified through E-Verify in accordance with applicable federal law. We are committed to providing a fair, transparent, and welcoming hiring experience for all candidates.
EEO Statement
It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances.
Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company.
For information related to our privacy notice, please review: Legend Biotech Privacy Notice.
Company
Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap.
For two years, Legend Biotech, then known as the “Legend Project,” operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies.
In 2015, Legend’s scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China.
In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world. CARVYKTI™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022.
Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies.
Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies.